OLANZAPINE
- Product NDC
- 13668-090
- 11-digit product format
- 136680090
- Labeler code
- 13668
- Product ID
- 13668-090_1a64829a-2434-4c8d-8e58-9b28758e4b88
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- OLANZAPINE
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Labeler
- Torrent Pharmaceuticals Limited
- Application
- ANDA091415
- Marketing category
- ANDA
- Marketing start
- 2011-10-25
- Substance
- OLANZAPINE
- Active strength
- 20 mg/1
- Pharmacologic classes
- Atypical Antipsychotic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- OLANZAPINE
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| OLANZAPINE | 20 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | N7U69T4SZR |
| Rxcui | 200034, 283639, 312076, 312077, 312078, 312079, 314154, 314155, 351107, 351108 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 13668-090-05 | OLANZAPINE | 500 in 1 BOTTLE | TABLET, ORALLY DISINTEGRATING | 500 | | 19 |
| 13668-090-30 | OLANZAPINE | 30 in 1 BOTTLE | TABLET, ORALLY DISINTEGRATING | 30 | | 19 |
| 13668-090-90 | OLANZAPINE | 90 in 1 BOTTLE | TABLET, ORALLY DISINTEGRATING | 90 | | 19 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| OLANZAPINE | ACTIVE INGREDIENT | N7U69T4SZR | OLANZAPINE TABLET OLANZAPINE TABLET, ORALLY DISINTEGRATING [TORRENT PHARMACEUTICALS LIMITED] | 6 | |
| OLANZAPINE | ACTIVE MOIETY | N7U69T4SZR | OLANZAPINE TABLET OLANZAPINE TABLET, ORALLY DISINTEGRATING [TORRENT PHARMACEUTICALS LIMITED] | 6 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | OLANZAPINE TABLET OLANZAPINE TABLET, ORALLY DISINTEGRATING [TORRENT PHARMACEUTICALS LIMITED] | 6 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | OLANZAPINE TABLET OLANZAPINE TABLET, ORALLY DISINTEGRATING [TORRENT PHARMACEUTICALS LIMITED] | 6 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | OLANZAPINE TABLET OLANZAPINE TABLET, ORALLY DISINTEGRATING [TORRENT PHARMACEUTICALS LIMITED] | 6 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | OLANZAPINE TABLET OLANZAPINE TABLET, ORALLY DISINTEGRATING [TORRENT PHARMACEUTICALS LIMITED] | 6 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | OLANZAPINE TABLET OLANZAPINE TABLET, ORALLY DISINTEGRATING [TORRENT PHARMACEUTICALS LIMITED] | 6 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 13668-090 | OLANZAPINE TABLET OLANZAPINE TABLET, ORALLY DISINTEGRATING [TORRENT PHARMACEUTICALS LIMITED] | 17 | Current NDC, Legacy NDC, 3 package rows | 20250305_2cb1bebe-0ced-46d8-bf21-c28a9acc4a15.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 13668-090-05 | 13668009005 | 500 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (13668-090-05) | 2011-10-25 | 0000-00-00 | No | No | Current |
| 13668-090-30 | 13668009030 | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (13668-090-30) | 2011-10-25 | 0000-00-00 | No | No | Current |
| 13668-090-74 | 13668009074 | 100 TABLET, ORALLY DISINTEGRATING in 1 CARTON (13668-090-74) | 2011-10-25 | 0000-00-00 | No | No | Current |
| 13668-090-90 | 13668009090 | 90 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (13668-090-90) | 2011-10-25 | 0000-00-00 | No | No | Current |